Correction to: Novel Risk Engine for Diabetes Progression and Mortality in USA: Building, Relating, Assessing, and Validating Outcomes (BRAVO)

Pharmacoeconomics. 2019 Aug;37(8):1069. doi: 10.1007/s40273-019-00807-3.

Authors

Hui Shao¹, Vivian Fonseca², Charles Stoecker¹, Shuqian Liu¹, Lizheng Shi³

Affiliations

¹ Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 1900, New Orleans, LA, 70112, USA.
² School of Medicine, Tulane University, New Orleans, LA, USA.
³ Department of Global Health Management and Policy, School of Public Health and Tropical Medicine, Tulane University, 1440 Canal Street, Suite 1900, New Orleans, LA, 70112, USA. lshi1@tulane.edu.

PMID: 31098945
DOI: 10.1007/s40273-019-00807-3

Abstract

The original article can be found online.

Publication types

Published Erratum